Cytokinetics, Inc. (CYTK) reported fourth-quarter net loss of $12.5 million wider than $10.9 million in the prior year period. On a per share basis, net loss was $0.21, narrower than $0.22 in the same quarter last year.
Revenues for the quarter decreased to $1.0 million from $3.2 million in the previous year period.
On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.22 per share on revenues of $2.90 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com